Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
Would you offer radiation therapy post lumpectomy for a small melanoma oligometastasis with negative margins?
If so, would you favor 30 Gy/5 fraction accelerated partial breast irradiation?
Answer from: Radiation Oncologist at Community Practice
I don’t know if RT will have benefits for melanoma with negative margins.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
Agree with Dr. @Beriwal, with oligomet with negative margins, I would watch.
Comments
Medical Oncologist at University of Virginia
Consider adjuvant systemic therapy for completely ...
7990
Sign in or Register to read more
15569
15573
Related Questions
How would you approach the radiation treatment of multiple recurrent lentigo maligna on the sole of the foot in an active patient not desiring further surgery?
In what situations would you recommend adjuvant radiation therapy for patients with locally advanced and/or recurrent basal cell carcinoma that receive vismodegib followed by surgery?
How would you treat a basal cell carcinoma on the temporal skin and zygomatic area s/p excision with PNI and significant flaps for closure?
How would you treat locally advanced melanoma of the scalp with several in transit lesions and a metastatic lesion to the parotid if the patient is progressing on immunotherapy such as pembrolizumab?
When do you recommend SRT, if ever, for small SCCs and BCCs?
For a cutaneous malignancy near the eyelid, how do you decide whether to use an internal eye shield or an external eye shield during treatment?
How would you manage a scalp squamous cell carcinoma s/p Mohs with high risk features who underwent placental grafting to expedite the healing process?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
How would you manage BCC to the left cheek after only half of a radiation course was completed three months ago and non-operative management is preferred?
When would you offer neoadjuvant immunotherapy prior to Mohs surgery in a locally advanced squamous cell carcinoma for which clearance may require enucleation?